Remedy has published its financial results for 2023, and reported a 22.2% decrease in revenue to €33.9 million compared to €43.6 million during the same period last year.
The Finnish developer reported an operating loss of €28.6 million for its full-year results, but noted that it received €5.2 million in royalties from Alan Wake Remastered.
Q4 2023:
FY 2023:
Remedy attributed the decline in revenue and profit to "increased investments" in ongoing projects currently in development, in addition to an impairment charge of €7.2 million for its project codenamed Kestrel (previously Vanguard) after the firm announced it would be changing the title from a free-to-play multiplayer to a premium title last November.
The report also included results for the three months ended December 2023, with revenue declining by 24.4% to €10.3 million, and operating profit at a loss of €12.8 million.
Despite Remedy describing 2023 as a "challenging year," its CEO Tero Virtala highlighted the release of Alan Wake 2 in October as a major success for the developer.
"The sales of Alan Wake 2 started well despite a competitive launch window," Virtala said. "Alan Wake 2 has already recouped a significant part of the investments made by Epic Games Publishing, and we expect the game to be a meaningful revenue and profitability driver for the year."
He added: "With Alan Wake and Control we now have two established franchises, and our ambition is to grow them into franchises that have high brand recognition, steadily growing user base, more regular cadence of sequels and an ability to generate revenue and profits and a high level."
Speaking of Control, Remedy acquired the full publishing rights to the franchise from 505 Games for €17 million at the end of its fourth quarter. It now owns the rights to the original game, its sequel, and the multiplayer spin-off codenamed Condor that is currently in development.
As for other projects currently in development, Virtala said that the remakes of Max Payne 1 and
Read more on gamesindustry.biz